Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959
ORIGINAL
From cross-section to prognosis: risk factors for renal function deterioration in primary hyperparathyroidism
Takuma YamotoMasakazu Notsu Keizo Kanasaki
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML

2026 Volume 73 Issue 8 Pages 939-949

Details
Abstract

Renal dysfunction is an important complication of primary hyperparathyroidism (pHPT). However, the factors associated with a decline in estimated glomerular filtration rate (eGFR) in patients with pHPT have not been fully investigated. This study aimed to identify the factors associated with reduced eGFR at diagnosis in patients with pHPT, and the determinants of longitudinal eGFR decline among those with follow-up data. Eighty-nine patients with pHPT were categorized by renal function at diagnosis. In addition, the annual eGFR decline rate was assessed in 47 patients with more than one year of follow-up. Clinical and biochemical variables were analyzed to determine their association with renal function. Compared with the normal renal function group, the reduced renal function group (eGFR <60 mL/min/1.73 m2) had higher age, and uric acid levels, lower diastolic blood pressure, daily urinary calcium (Ca) excretion, and % tubular reabsorption of phosphate (%TRP). In the multivariable logistic regression analysis, a low %TRP remained significantly associated with reduced renal function at diagnosis. Patients with an eGFR decline faster than –3 mL/min/1.73 m2 per year had significantly higher serum chloride and 25-hydroxyvitamin D levels, and lower HbA1c levels than those with a slower decline. Logistic regression analysis showed, that higher serum chloride levels were associated with a faster annual decline in eGFR. In conclusion, reduced eGFR at pHPT diagnosis was associated with lower %TRP, whereas a faster annual eGFR decline was associated with higher serum chloride levels.

Fullsize Image
Content from these authors
© The Japan Endocrine Society

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top